Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company operates as a pharmaceutical company.
Hetero Labs Limited, is an unlisted public company incorporated on 10 March, 1989. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 320.00 cr and the total paid-up capital is INR 277.06 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | 6,975.3 | 10,215.8 | 9,663.1 | 10,621.9 | 10,597.3 |
Operating profit | 959.1 | 1,942.6 | 1,397.4 | 1,700.6 | 1,762.0 |
Net profit | 563.1 | 1,225.6 | 825.6 | 914.8 | 782.1 |
Gross margin | 38.5 | 42.9 | 38.8 | 40.3 | 43.5 |
Operating margin | 13.8 | 19.0 | 14.5 | 16.0 | 16.6 |
Net margin | 7.8 | 11.9 | 8.4 | 8.4 | 7.3 |
Networth | 5,242.4 | 6,482.8 | 7,296.8 | 8,199.6 | 8,967.3 |
Borrowings | 3,431.5 | 3,090.7 | 3,596.6 | 3,605.1 | 3,802.0 |
Assets | 11,183.6 | 12,022.2 | 13,020.6 | 14,399.6 | 15,498.5 |
Debt to equity | 0.7 | 0.5 | 0.5 | 0.4 | 0.4 |
Current ratio | 1.4 | 1.6 | 1.5 | 1.6 | 1.6 |
ROE | 10.7 | 18.9 | 11.3 | 11.2 | 8.7 |
Days payable | 139.0 | 106.0 | 95.0 | 113.0 | 123.0 |
WC days | 110.0 | 96.0 | 99.0 | 107.0 | 118.0 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | 1.3 | 277.1 | 277.1 | 277.1 | 277.1 |
Reserves | 5,241.0 | 6,205.7 | 7,019.8 | 7,922.6 | 8,690.2 |
Borrowings + | 3,431.5 | 3,090.7 | 3,596.6 | 3,605.1 | 3,802.0 |
Long term borrowings | 691.8 | 533.2 | 319.5 | 365.1 | 286.0 |
Short term borrowings | 2,739.7 | 2,557.5 | 3,277.1 | 3,240.0 | 3,515.9 |
Trade payables + | 1,637.5 | 1,694.3 | 1,545.9 | 1,966.2 | 2,020.7 |
Days payable | 139.0 | 106.0 | 95.0 | 113.0 | 123.0 |
Other liabilities + | 2,509.8 | 2,448.8 | 2,127.2 | 2,594.9 | 2,729.2 |
Other non-current liabilities | 419.5 | 366.9 | 369.2 | 378.3 | 415.6 |
Other current liabilities | 452.8 | 387.6 | 212.0 | 250.3 | 292.9 |
Total liabilities | 11,183.6 | 12,022.2 | 13,020.6 | 14,399.6 | 15,498.5 |
Fixed Assets + | 2,275.4 | 2,337.2 | 2,722.7 | 3,010.8 | 3,112.4 |
Tangible assets | 2,091.4 | 2,084.8 | 2,279.7 | 2,453.6 | 2,652.6 |
CWIP | 46.7 | 122.1 | 182.2 | 305.0 | 185.7 |
Intangible assets | 137.3 | 130.2 | 260.9 | 252.2 | 274.1 |
LT loans and advances | 812.7 | 800.4 | 868.5 | 1,021.4 | 1,251.2 |
Other non-current assets | 1,166.6 | 1,554.7 | 1,777.2 | 1,789.0 | 1,874.5 |
Current assets + | 6,928.9 | 7,329.9 | 7,652.2 | 8,578.3 | 9,260.3 |
Inventories | 2,730.2 | 3,052.6 | 3,280.1 | 3,730.7 | 4,294.4 |
Trade receivables | 3,626.0 | 3,756.2 | 3,887.4 | 4,013.2 | 4,062.6 |
Cash and cash equivalents | 14.9 | 40.6 | 44.9 | 301.2 | 279.8 |
ST loans and advances | 19.5 | 27.9 | - | - | - |
Other current assets | 538.3 | 452.7 | 439.9 | 533.3 | 623.4 |
Total assets | 11,183.6 | 12,022.2 | 13,020.6 | 14,399.6 | 15,498.5 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | 6,975.3 | 10,215.8 | 9,663.1 | 10,621.9 | 10,597.3 |
Sales growth % | 5.15 | 46.46 | -5.41 | 9.92 | -0.23 |
Expenses + | 6,518.3 | 8,670.2 | 8,618.6 | 9,455.8 | 9,411.4 |
Cost of goods | 4,290.1 | 5,834.6 | 5,915.2 | 6,338.5 | 5,989.5 |
Employee cost | 675.3 | 799.0 | 872.8 | 996.6 | 1,091.6 |
Other costs | 1,050.9 | 1,639.6 | 1,477.6 | 1,586.2 | 1,754.2 |
Operating profit + | 959.1 | 1,942.6 | 1,397.4 | 1,700.6 | 1,762.0 |
Operating margin % | 13.8 | 19.0 | 14.5 | 16.0 | 16.6 |
Other income | 246.6 | 89.9 | 157.9 | 223.1 | 154.1 |
Interest | 313.2 | 210.3 | 155.6 | 326.0 | 337.3 |
Depreciation | 188.9 | 186.7 | 197.2 | 208.6 | 238.8 |
Exceptional items | - | - | - | - | -120.6 |
Profit before tax | 703.7 | 1,635.4 | 1,202.4 | 1,389.1 | 1,219.3 |
Tax | 140.6 | 409.8 | 376.8 | 474.4 | 437.3 |
Profit - disc. ops | - | - | - | - | - |
Net profit | 563.1 | 1,225.6 | 825.6 | 914.8 | 782.1 |
Net margin % | 7.8 | 11.9 | 8.4 | 8.4 | 7.3 |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | 0.7 | 0.5 | 0.5 | 0.4 | 0.4 |
Net Debt/Equity | 0.7 | 0.5 | 0.5 | 0.4 | 0.4 |
Total Debt/Assets | 0.3 | 0.3 | 0.3 | 0.2 | 0.2 |
Total Assets/Equity | 2.1 | 1.9 | 1.8 | 1.8 | 1.7 |
Liquidity + | |||||
Current Ratio | 1.4 | 1.6 | 1.5 | 1.6 | 1.6 |
Quick Ratio | 0.9 | 0.9 | 0.9 | 0.9 | 0.8 |
Interest Coverage | 3.1 | 9.2 | 9.0 | 5.2 | 5.2 |
Performance | |||||
Gross Margin | 38.5 | 42.9 | 38.8 | 40.3 | 43.5 |
Operating Margin | 13.8 | 19.0 | 14.5 | 16.0 | 16.6 |
Net Margin | 7.8 | 11.9 | 8.4 | 8.4 | 7.3 |
Return + | |||||
Return on Equity | 10.7 | 18.9 | 11.3 | 11.2 | 8.7 |
Pre-tax ROCE | 17.6 | 34.9 | 22.5 | 24.3 | 23.3 |
Return on Assets | 5.0 | 10.2 | 6.3 | 6.3 | 5.0 |
Pre-tax ROIC | 8.9 | 18.4 | 11.1 | 13.0 | 12.2 |
Efficiency + | |||||
Days Payable | 139.0 | 106.0 | 95.0 | 113.0 | 123.0 |
Days Inventory | 232.0 | 191.0 | 202.0 | 215.0 | 262.0 |
Days Receivable | 190.0 | 134.0 | 147.0 | 138.0 | 140.0 |
Fixed Asset Turnover | 3.1 | 4.4 | 3.5 | 3.5 | 3.4 |
Total Asset Turnover | 0.6 | 0.8 | 0.7 | 0.7 | 0.7 |
Working Capital | |||||
Cash Conversion Cycle | 283.0 | 219.0 | 254.0 | 240.0 | 279.0 |
Working Capital Days | 110.0 | 96.0 | 99.0 | 107.0 | 118.0 |
IDBI Trusteeship Services Limited
No. of Loans: 1
Total Amount : 5,200.5 cr
State Bank of India
No. of Loans: 4
Total Amount : 700.4 cr
Mahindra and Mahindra Financial Services Limited
No. of Loans: 47
Total Amount : 24.5 cr
HDFC Bank Limited
No. of Loans: 6
Total Amount : 0.8 cr
Union Bank of India
No. of Loans: 3
Total Amount : 0.5 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 0.2 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Parthasaradhi Reddy Bandi
Shareholder
|
00015899 | 28 years |
Director | Srinivas Reddy Male | 00016085 | 17 years |
Whole-time Director | Venkatanarasa Reddy Attunuri | 00023432 | 11 years |
Whole-time Director | Mohana Reddy Chilukuri | 00208921 | 25 years |
Director | Rathnakar Reddy Kura | 00211510 | 11 years |
Managing Director | Bandi Vamsikrishna
Shareholder
|
01014619 | 17 years |
Director | Vasudevan Sujesh | 08240092 | 1 years |
Director | Govindaraju Bhavani | 09657046 | 2 years |
CFO | Bhavesh Bansidhar Pujara | <HIDDEN> | 2 years |
CS | Sudershan Pallap | <HIDDEN> | 4 years |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Camber Pharmaceuticals Inc | United States | - | - |
Hetero Singapore PTE Ltd | Singapore | - | - |
Camber Consumer Care Inc | United States | - | - |
Hetero Australia PTY LTD | Australia | - | - |
Hetero Labs Nigeria Limited | Nigeria | - | - |
DMN Invest LLC | Russian Federation | - | - |
Makiz Pharma LLC | Russian Federation | - | - |
HETERO WIND POWER (PENNAR) PRIVATE LIMITED | Telangana | 2015 | ₹ 65.0 Cr |
Hetero FZCO | United Arab Emirates | - | - |
HETERO MED SOLUTIONS LIMITED | Telangana | 2007 | ₹ 32.2 Cr |
HETERO WIND POWER LIMITED | Telangana | 2010 | ₹ 154.0 Cr |
ASPIRO PHARMA LIMITED | Telangana | 2014 | ₹ 254.1 Cr |
Hetlabs Mexico S.A. DE C.V | Mexico | - | - |
Akar Columbia SAS | Colombia | - | - |
Hetero Kenya Limited | Kenya | - | - |
Hetero Malta Limited | Malta | - | - |
Excellan Peru SAC | Peru | - | - |
Camber Pharma Mexico S A De C V. | Mexico | - | - |
Hetero Philippines Inc. | Philippines | - | - |
HETERO WIND POWER (ANANTA) PRIVATE LIMITED | Telangana | 2015 | ₹ 25.0 L |
HETERO WIND POWER (RAYALA) PRIVATE LIMITED | Telangana | 2015 | ₹ 50.0 L |
Pharmed Healthcare Company SAE | Egypt | - | - |
Hetero (Thailand) Limited | Thailand | - | - |
ANNORA PHARMA PRIVATE LIMITED | Telangana | 2015 | ₹ 286.0 Cr |
WALLET PHARMA PRIVATE LIMITED | Telangana | 2015 | ₹ 98.0 Cr |
EVARIC PHARMA PRIVATE LIMITED | Telangana | 2015 | ₹ 1.0 L |
HETERO BIOTECH LIMITED | Telangana | 2004 | ₹ 5.0 L |
The incorporation date of HETERO LABS LIMITED is 10 March, 1989
The authorized share capital of HETERO LABS LIMITED is INR ₹ 320.0 Cr.
The paid-up capital of HETERO LABS LIMITED is INR ₹ 277.1 Cr.
The registered address of HETERO LABS LIMITED is #7-2-A2, Industrial Estate, Sanath Nagar, Sanathnagar I E Balanagar Hyderabad Telangana - 500018
The CIN number of HETERO LABS LIMITED is U24110TG1989PLC009723.